chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After first short only had a little area around needle that felt sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (After first short only had a little area around needle that felt sore) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concomitant products included EICOSAPENTAENOIC ACID ETHYL ESTER (VASCEPA), SIMVASTATIN, DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE (FARXIGA), OLMESARTAN, METOPROLOL, URSODIOL and VITAMINS NOS for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (After first short only had a little area around needle that felt sore). At the time of the report, MYALGIA (After first short only had a little area around needle that felt sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment medication was not provided.
75 year old complained of anxiety after receiving the vaccine. Onsite EMS was called BP 146/78  99% O2 HR 96. She refused further evalvation & care.
Information has been received from a registered nurse concerning a co-workers 5 year old son who was vaccinated at the age of 18 months with a 0.5 mL SC dose of varicella virus vaccine live. Subsequently the patient developed breakthrough varicella. The patient was sick for 6 days and had over 50 lesions. Unspecified medical attention was sought. The patient subsequently recovered. There was no product quality complaint involved. Additional information has been requested.
On 3/12/2022 my face was feeling very hot and then I noticed my entire face was covered in a raised, red rash. It was covering my cheeks, chin, and upper lip area. It was rad and warm, not itchy.  I took Ibuprofen and after two days now it seems to have gone almost completely away.
Left arm tenderness,  Fatigue,  Muscle and Joint pain,  Headache.  Pain is continual and has not sought treatment so far.
Body aches and soreness in arm where shot was given. Next day she had fast heartbeat and felt like she was going pass out. Her body hurt too.
she feels like she has a cold; scratchy throat; runny nose; Coughing; This is a spontaneous report from a contactable consumer or other non hcp (Patient herself). Follow-up (15Feb2021) received from a consumer via Pfizer-sponsored program  was processed together with initial information.   A 68-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via intramuscular route of administration on 26Jan2021 around 02:00 Pm, (Batch/Lot Number: EL8982) as 1st dose in left arm shoulder, single for COVID-19 immunization. Medical history included colonoscopy 10 days ahead of her COVID-19 vaccine. She was given some type of drug then. She explains she had a Covid test right before the colonoscopy. She clarifies she had the COVID-19 test on 12Jan2021, and then on 14Jan2021, she had the actual colonoscopy, and she was given drugs at the time. She believes it was Fentanyl and a couple of others. No further details were provided. The patient's concomitant medications were not reported. On an unspecified date the patient had felt like she has cold, scratchy throat, she sneezed a couple times and had a little bit of a runny nose (It's not like she is sick. It's not a real cold or an advancing cold) and a little cough but that went away. She said she has a residual feeling that something was there, so she thinks it is on it'd way out. It was reported that scratchiness was not totally gone. Outcome of cough was recovered, scratchiness in her throat was resolving while for other events is unknown.  No further details were provided or obtained. Follow-up attempts completed. No further information expected.
This case was reported by a healthcare professional and described the occurrence of pain around injection site in a 30-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). Concurrent medications included Multivitamin. On 21 September 2011 at 08:00 the subject received a dose of FLUARIX (unknown route, right arm). On 17 October 2011, 26 days after vaccination with FLUARIX, the subject experienced pain around injection site. She also experienced arm pain, arm numbness and hard to move arm. The pain around injection site started the week of 17 October 2011 and had progressively worsened. The subject reported that she first noticed the pain when writing on the chalkboard. She writes on the board all day and the pain usually started later in the day. The subject noted that the pain started around the area of injection and had gotten worse so that she had difficulty writing on the board. In the later afternoon when her arm is parallel to her side, the subject reported that her arm started to go numb and the numbness extends down to her fingers. The numbness was worse when her arm was by her side. The subject reported that when she was using her right arm (arm of injection) it was hard to lift. On 25 October 2011, the subject experienced a sharp pain in her arm when lifting her arm to brush her hair, and she dropped the hairbrush. The subject had not yet consulted her physician regarding the events. The healthcare professional considered the events were disabling. At the time of reporting the events of pain around injection site, arm pain and arm numbness were worse. The outcome of the hard to move arm event was unknown.
This spontaneous report as received from the nurse practitioner refers to a  50 year old male patient. Concomitant medications, medical history, concurrent conditions, drug allergies were not reported. On 27-MAR-2015, the patient was vaccinated with ZOSTAVAX (lot # K020186 with the expiration date of 27-JAN-2016), 0.65 milliliter (ml), 1 dose, subcutaneous. On 28-MAR-2015, 2 days after onset of therapy the patient experienced a large red spot at the site of vaccine administration. The large spot became stiff and began to itch. The patient emailed nurse and sought medical attention. No treatment was given. No product quality complaint involved. The outcome of events was reported as recovered/resolved on 06-APR-2015. This is one of several reports from the same reporter. Additional information has been requested.
TC from Mother on 5-11-06, LT upper arm red - 4" circ. feels hot to touch, hard center - Redness elevated to neck area, no generalize fever, Sl swelling; 5-12-06 still swollen, Sl decreased redness in arm "fever in arm decreased"
Client c/o swelling, soreness bilateral upper areas & slight itching (L) upper arm.  Swelling started 9/8/09 pm & has increased.  Taking MOTRIN PRN & applying cool compresses.  9/10/09 815AM Edema with slight redness & warmth (L) deltoid are 14x18cm, (R) deltoid area edema 8x4cm.  T- 98.1
Received injection 2/1/02. 24 hours after injection,my arms itched, face was swollen, itched all over. Unable  to wear contacts. discolored skin where bandaid placed. Little tightness in chest on Sat 2/2/02 only. Swelling stayed the same until seen by PMD on 2/4/02. given Benadryl 25 , 50 mg tid for the first day, second day took 50 X2, 25 X1, third day 50 X1, 25 X 2, Eyelids were swollen
This spontaneous report was received from an office manager referring to an unknown number of patients of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of M-M-R II, lot # K024824, expiration date 02-DEC-2016, (dose number, route and anatomical location of administration were unknown). The temperature of excursion was 51 F for 30 minutes. There was no previous temperature excursion. The temperature excursion was detected by a digital data logger. No adverse experience had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Systemic Lupus Erythematosis, 2 days post vaccination, pt developed fever, nausea, vomiting, fatique, and arthralgias. 2 wks post vaccination, pt developed flu-like illness, cough, vomiting, diarrhea, fever, arthralgias, facial rash. 60 day follow-up received on 10/25/00 provided no additional data.
5 1/2 cm x 10 cm  area of erythema (R) upper arm; No pus or pain.
Information has been received from a physician concerning a female who was vaccinated with Gardasil. Subsequently the patient experienced laryngitis two days after receiving the vaccine. Medical attention was sought. The patient's outcome was not reported. Additional information has been requested.
soreness, really bad in my shoulder; soreness, really bad in my shoulder and left side of the neck; Dizzy; Achy bones; Hands were very stiff; sore; This is a spontaneous report from a contactable consumers (patient and patient's wife). A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9265 and expiry date: 31May2021), via an unspecified route of administration on 30Jan2021 at single dose for COVID-19 immunization. Medical history included blood pressure and cholesterol from an unknown date and unknown if ongoing. Concomitant medication included metoprolol for blood pressure and atorvastatin (lot number: E003816) for cholesterol. The patient stated, "My wife and I have received Pfizer's COVID-19 Vaccine, yesterday, around this time, noon. I was fine. I didn't feel any discomfort in my shoulder but later on at night, it started getting sore on 30Jan2021. And then, this morning 31Jan2021, I woke up with a soreness, really bad in my shoulder, my left shoulder and also my left side of the neck. And I woke up really like dizzy and achy bones. My hands were very stiff which I have never experienced that. And I was a little scared if that was a side effect and if they are going to continue for a long time? No lab work done". The patient took Tylenol or Aleve 6 hours apart as treatment for the events. The outcome of the events was unknown.
On 8/1/18, patient experienced fever of 100 degrees F, upper arm pain at site of injection, fatigue, and malaise. Took ibuprofen with some relief.
pt called 6/3 and stated she developed a rash on her upper back shoulder on 6/2. she noticed today 6/3 it's across her chest. told her to keep an eye on it and see how bad it gets and might have to see dr but right now take some benadryl and hydrocortisone cream otc.
This spontaneous report as received via a company representative from a female patient under fifty year old, who is also a Certified Nursing Assistant concerning herself. Information regarding the patient's concurrent conditions and medical history was not provided. On an unknown date, when the patient was "under fifty", she was possible vaccinated with ZOSTAVAX (dose, route of administration, anatomical location and expiration date were not provided). There were no concomitant medications provided. On an unknown dates, on three separate occasions, the patient developed shingles. The outcome of shingles and the casual relationship were not provided. Additional information has been requested.
Information has been received from a medical assistant referring to an adult female patient with unknown age. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions, and allergies were not reported. On an unspecified date (reported as in her youth), the patient received immunization series of VARIVAX for prophylaxis (Dosage schedule, strength, route, anatomical location, lot number and expiration date were not reported); however on an unspecified date, the patient had a varicella virus test which showed lack of immunity to varicella virus. On approximately November 2017, the patient received another dose of VARIVAX for prophylaxis (Dosage schedule, strength, route, anatomical location, lot number and expiration date were not reported) and later at approximately December 2017, the patient was vaccinated with another dose of VARIVAX intramuscularly (lot number M049127 and Expiration date of 15-DEC-2018) (dosage schedule, anatomical location, and strength were not reported); however the reporter stated that the patient had no adverse events since her last vaccination. Other suspect therapies included a sterile diluent (Dosage schedule, strength, route, anatomical location, lot number and expiration date were not reported). The relatedness between the suspect therapies and the lack of immunity to varicella virus was not reported.
Mom noted on 6/22 both arms (deltoid area) are swollen, red and warm to touch. Left more than the right. Fever for 24 hrs only after injection; MD described, (L) arm has erythema, raised, indurated and warm to touch 3 1/4 inch x 3 1/2 inch; Cephalexin 250 mg/ml - 6.5 ml TID x 10 days.
Information has been received from a physician concerning a 8 week old patient with no pertinent medical history and no drug reaction/allergies who was vaccinated with first oral dose of Rotateq. Concomitant therapy included the other two month vaccinations. Subsequently, the patient experienced vomiting and went limp several hours after receiving Rotateq live. Subsequently, the patient recovered from vomiting and went limp. The patient sought unspecified medical attention. Additional information has been requested.
left sided chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (left sided chest pain) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma (well controlled, worse after booster) since 1994, Hypertension (well controlled) since 2012, Type 2 diabetes mellitus (well controlled) since 2012, High cholesterol since 2012, Anxiety, Drug allergy and Drug allergy. Concomitant products included METFORMIN HYDROCHLORIDE (METFORMIN ER) for Diabetes, ROSUVASTATIN for High cholesterol, AMLODIPINE for Hypertension, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA) and IRON for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHEST PAIN (left sided chest pain). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency; ALBUTEROL [SALBUTAMOL] for Asthma, at a dose of UNK, inhalation; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and ALPRAZOLAM (XANAX) for Adverse event, at a dose of 0.5 milligram. On 08-Mar-2021, CHEST PAIN (left sided chest pain) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-370271, MOD-2021-370396, MOD-2021-369443 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Nov-2021: Significant follow-up(contact info updated, Form contains medical history and conmeds updated) On 04-Nov-2021: Follow up received and contains no new information On 05-Nov-2021: Follow up received  contains NNI.; Sender's Comments: This case concerns a 43-year-old, female, with relevant reported medical history of Type II Diabetes, Hypertension, Asthma, High Cholesterol and Anxiety, who experienced the non-serious unexpected event of Chest pain. The event occurred 15 minutes after the administration of the first dose of mRNA-1273. At the time of the report, the outcome for the event is Recovered/Resolved. The Rechallenge is positive because the SD states that the patient recovered from the event after receiving the first dose, but the same event appeared after receiving the second dose. The reported medical history of Type II Diabetes, Hypertension, Asthma, High Cholesterol and Anxiety remains as a confounder for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.
ARM WAS RED, SWOLLEN, AND HAD CELLULITUS IN THE SITE WHERE THE VACCINE WAS ADMIN.LEFT ARM (DTAP & POLIO) WERE ADMIN AT THIS SITE
1/11/2022 - Left axillary pain and swelling started; treated with 2 tablets of over-the-counter (OTC) Advil Dual Action. 1/12/2022 - Left axillary pain and swelling intensified; treated with 2 tablets of OTC Advil Dual Action twice a day and moist heat compresses. 1/13/2022 - Left axillary pain and swelling continues; treated with 2 tablets of OTC Advil Dual Action twice a day, heating pad, and 1 oxycodone tablet at bedtime. 1/14/2022 - Left axillary pain and swelling continues with pain now extending to left elbow; took 2 tablets of OTC Advil Dual Action in AM, using heating pad, contacted employer' and also contacted PCP office (waiting for return call from PCP's office as of 10:52 AM)
At 11:00pm that evening I started to run a low grade fever, I felt myself "tanking out".  I woke up in the middle of the night and my fever was 101 degrees.  I felt so bad and had the chills. The following day I slept 22 hours because I felt so bad.  The next day after that I slept about 19 hours and this went on for the next few weeks.  I felt like I had not energy.  I started to question "What did I do?"  I also had a horrible headache.  I was also having a hard time concentrating and focusing.  I was so sick from the second dose.  I have never felt this bad in my life or have ever been this sick in my life.
Information has been received from a Registered Nurse concerning a female between the ages of 60-70 who on an unspecified date was vaccinated with zoster vaccine live (Oka/Merck). Subsequently, the patient had a sore arm and discomfort after receiving zoster vaccine live (Oka/Merck). Additional information has bee requested. This is one of several reports from the same source.
Initial report received on 16 September 2013 from a vaccine provider. A 74-year-old female patient, whose medical history included yearly flu shot, concomitant medications was not reported, received a dose of FLUZONE HD (lot # U4714AA) at left deltoid intramuscularly on 14 September 2013). It was reported that a patient have received the FLUZONE ID. On 16 September 2013. Patient reported body aches and pulsating veins in her head. The events were resolving. List of documents held by sender: none
History of non-Hodgkin's lymphoma.  Has had a 4-day history of fever, chills, sore throat, and URI symptoms/congestion.
The vaccine given at day 33 from fridge storage, rather than within the 30-days after thawing.
Headache throughout the night and continuing into the morning. Took Tylenol but still present. Sore arm at injection site.
11-14 Flu shot in right arm at approx. 10:00. 11-14 10:30am have headache. 11-14 3:00pm right arm is very sore, hot and swollen at injection site. 11-14 10:00pm have chills and headache-took TYLENOL. 11-15 2:00am has dry heaves every hour until 6:00am. 11-15 Called Clinic and reported reaction. 11-16 Went to PCP-gave Rx for 3 Prednisone. 11-19 Felt very lethargic and swelling is traveling down arm into elbow. 11-20 10:45am Went to PCP again and he admitted him to local hospital. 11-20 1:00pm was admitted and during this time he started vomiting, having chills and high fever (102.6). 11-20 3:00 shot of PHENERGAN, then administered IV's. Took X-rays, CT scan, Blood Work and urinalysis. 11-22 10:00am was dismissed from hospital. Not sure of types of blood work, fax will include report from hospital on blood work.
The patient presented to ED on 03/01/2022 for worsening hypoxia and fever.  He was treated and sent home on 03/04/2022 with supplemental oxygen.  A few hours later the patient's daughter noted his oxygen saturation in the 70s, he was confused and had slurred speech.  He returned to the hospital and suffered a cardiac arrest in the ED and was intubated.  The patient continued to decline with worsening neurological functions.  The patient was made comfort care on 03/14/2022.  The patient required high doses of fentanyl to treat dyspnea.  The patient was transferred on 03/15/2022 for end-of-life care. The patient expired on 03/17/2022.
Received PF FLUZONE 10-22-14. Noted fever 103.1 10-25-14. Seen urgent care 10-27-14.
Vaccination site is itchy; Vaccination site is swollen; Vaccination site is red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Vaccination site is itchy), VACCINATION SITE SWELLING (Vaccination site is swollen) and VACCINATION SITE ERYTHEMA (Vaccination site is red) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 025A21A) for COVID-19 vaccination.     The patient's past medical history included Colitis collagenous, Addison's disease and AFib. Concurrent medical conditions included Sulfonamide allergy. Concomitant products included DABIGATRAN ETEXILATE MESILATE (PRADAXA) and METOPROLOL for AFib, PREDNISONE for Addison's disease.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Vaccination site is swollen) and VACCINATION SITE ERYTHEMA (Vaccination site is red). On 19-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Vaccination site is itchy). At the time of the report, VACCINATION SITE PRURITUS (Vaccination site is itchy) outcome was unknown and VACCINATION SITE SWELLING (Vaccination site is swollen) and VACCINATION SITE ERYTHEMA (Vaccination site is red) had resolved.            No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Patient demographics updated. Medical history were added. Suspected product date changed and dose added. Concomitant products indication were updated. Events outcome were updated.
Shortly after patient received this vaccine, he complained of tightness in this throat saying that he felt like someone was pressing on it and he felt his throat was tight. He had  no difficulty swallowing or breathing. He was alert with normal speech, had no stridor and his chest exam was normal. He did not have labored breathing. An EpiPen was administered and he was feeling better within a few minutes.  He did continue to complain of a little throat tightness but was better.   911 was called and he was transported to our local ED. At he hospital he was given Benedryl and prednisone.   Follow-up phone call he was improved and was referred to an allergist for evaluation. It was concluded that this reaction was not a manifestation of patient's anxiety as this is not how he reacts. He does not have an aversion or defensiveness to vaccines or needle sticks; and he did not turn down the EpiPen.   No further Bexsero vaccines will be given.
Case was hospitalized for Covid 4 months after being boosted with dose #3 Moderna Covid vaccine.  Briefly, this is a 66 y.o. male with PMH significant for CKD, htn, hld, renal transplant, OSA on cpap, left RTC tear s/p 6/dec TSA left. He presented to ED 18/dec with dyspnea, confusion and weakness and was found to have Covid-19 pneumonia which was diagnosed approximately on2 week before 18/dec admission. He had already been Covid vaccinated x2 and boostered. Treatment consisted of decadron for 10 days through discharge and patient received remdesivir while here until he was discharged 21/dec. His oxygen needs continued to decine daily while hospitalized and he required only room air at rest on day of discharge but 2L home o2 with exertion due to o2 desat to 86% with exertion on room air on day of discharge without cough or dyspnea or tachycardia or confusion. Local Hospital PRIVACY (NAME) MD